Z. Ronai et al., EXPRESSION OF A 32-KDA PROTEIN IN RAT MAMMARY-TUMORS INDUCED BY ANTI-BENZO[C]PHENANTHRENE-3,4-DIOL-1,2-EPOXIDE, International journal of cancer, 67(1), 1996, pp. 124-128
Racemic anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide (BcPDE) is a po
werful rat mammary carcinogen and a metabolite of benzo[c]phenanthrene
, a polynuclear aromatic hydrocarbon found in the environment. In eluc
idating potential molecular mechanisms that may play a role in the dev
elopment of BcPDE-induced rat mammary tumors, we have identified a 32
kDa protein in 16 of 26 tumors analyzed but in only 1 of the 15 normal
mammary tissues that were examined. The 32 kDa protein was identified
with antibodies to Ets, which also recognized the 55 kDa Ets-l protei
n that was expressed at similar levels in normal mammary tissues. The
expression of the 32 kDa protein was also observed in mammary tumor-de
rived cell lines of both rat and human origin and in human melanoma, b
ut not in normal human keratinocytes or rat fibroblast cell lines. Fur
ther characterization via 2D gels revealed that the protein exhibits a
PI of 5.5. Southwestern analysis using Ets-l target sequence revealed
binding of the 55 kDa Ets-l but not of the newly identified 32 kDa pr
otein. Overall, the preferential expression of the 32 kDa protein in m
ammary tumor tissues may serve as a biomarker to follow the developmen
t of this tumor type. (C) 1996 Wiley-Liss, Inc.